Loading…
Loading…
DGX · NYSE · Healthcare
“While everyone chases flashy tech moats, Quest quietly built an unscalable fortress of patient data and lab infrastructure that competitors can't replicate overnight.”
— In the voice of Munger
Evaluate financial health using Piotroski F-Score criteria — profitability, leverage, and operating efficiency metrics.
Market Cap
$21.72B
P/E Ratio
21.89
Forward P/E
—
EPS
$8.87
PEG Ratio
1.88
Book Value
$64.45
Dividend Yield
1.63%
Profit Margin
8.99%
ROE
13.84%
Use the interactive quality score with pre-loaded data for Quest Diagnostics Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for DGX: